BOSTON SCIENTIFIC CORP (BSX) revenue & profit

BOSTON SCIENTIFIC CORP (BSX): revenue $20.1B, net income – in 2025; latest quarter +7.5% year over year. From SEC filings.

$20.1BRevenue 2025

TickerBSX (NYSE)

IndustryHealthcare · Surgical & Medical Instruments & Apparatus

Revenue 2025$20.1B

Net income 2025–

Net margin–

Annual revenue growth+19.9%

Latest quarter (2026 Q2) · Revenue$5.4B

vs. same quarter last year+7.5%

Annual revenue & net income

Year	Revenue	Net income
2022	$12.7B	–
2023	$14.2B	–
2024	$16.7B	–
2025	$20.1B	–

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Unknown authorUnknown author · Public domain · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.